What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Neurotransmitter
Michel Hamon mainly focuses on Internal medicine, Endocrinology, Receptor, Serotonin and Neuroscience.
His studies in Endocrinology integrate themes in fields like 5-HT1A receptor, Agonist, Raphe nuclei, Ipsapirone and Dorsal raphe nucleus.
His Receptor study integrates concerns from other disciplines, such as Hippocampal formation, Hippocampus and Central nervous system.
His research in Central nervous system intersects with topics in Neuropathic pain, Pharmacology, Hyperalgesia and Spinal cord.
Michel Hamon has researched Serotonin in several fields, including Antidepressant and Dopamine.
His Neuroscience research is multidisciplinary, incorporating perspectives in Neurotrophic factors and Cell biology.
His most cited work include:
- Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension (478 citations)
- Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. (472 citations)
- Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. (411 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Endocrinology, Receptor, Serotonin and Pharmacology.
His work in 5-HT receptor, Serotonin transporter, Raphe nuclei, Neurotransmitter and Dopamine are all subfields of Internal medicine research.
His Endocrinology study combines topics from a wide range of disciplines, such as Agonist, Raphe, Dorsal raphe nucleus and Spinal cord.
His Receptor research incorporates elements of Molecular biology, Hippocampus and Binding site.
His work deals with themes such as Pulmonary hypertension and Neuroscience, which intersect with Serotonin.
The various areas that Michel Hamon examines in his Pharmacology study include Antidepressant, Agomelatine, Anxiolytic and Opioid.
He most often published in these fields:
- Internal medicine (55.08%)
- Endocrinology (54.10%)
- Receptor (30.00%)
What were the highlights of his more recent work (between 2010-2021)?
- Pharmacology (24.59%)
- Neuroscience (25.57%)
- Internal medicine (55.08%)
In recent papers he was focusing on the following fields of study:
Michel Hamon mainly investigates Pharmacology, Neuroscience, Internal medicine, Endocrinology and Neuropathic pain.
Michel Hamon combines subjects such as Antidepressant, Agomelatine, Agonist, Autoreceptor and Blockade with his study of Pharmacology.
His research integrates issues of Synaptic plasticity, Baroreflex, Nociception, Neurotrophic factors and Serotonin in his study of Neuroscience.
His study with Serotonin involves better knowledge in Receptor.
Michel Hamon regularly ties together related areas like Ethanol in his Internal medicine studies.
His Neuropathic pain research is multidisciplinary, incorporating elements of Sciatic nerve, Chronic pain, Tropomyosin receptor kinase B and Allodynia.
Between 2010 and 2021, his most popular works were:
- Monoamine neurocircuitry in depression and strategies for new treatments. (275 citations)
- Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. (197 citations)
- Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism (146 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
